id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-E-0048-0006,FDA,FDA-2007-E-0048,Determination of Regulatory Review Period for Purposes of Patent Extension; NEUPRO TRANSDERMAL SYSTEM - Notices,Notice,N-Notice,2009-05-08T04:00:00Z,2009,5,2009-05-08T04:00:00Z,2009-07-08T03:59:59Z,2009-05-08T17:08:56Z,E9-10818,0,0,090000648097f9a6
FDA-2007-E-0048-0005,FDA,FDA-2007-E-0048,FDA/CDER to US Patent and Trademark Office -  Letter,Other,LET-Letter,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2009-04-28T19:36:01Z,,0,0,090000648096e75e